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ABSTRACT 
In this study, a porous chitosan (CS)-organically modified montmorillonite (OM)-hydroxyapatite 
(HA) composite was developed by combining microwave irradiation and gas foaming method. 
The prepared composite was characterized using X-ray diffraction (XRD), attenuated total 
reflectance-fourier transform infrared (ATR-FTIR) spectroscopy, and scanning electron 
microscopy (SEM). The synergistic effect of OM and HA on the mechanical and in vitro 
biological properties (swelling, degradation and protein adsorption) of the composite were 
evaluated. In addition, the in vitro bioactivity of the composites was studied in simulated body 
fluid (SBF) for 21 days. The XRD results revealed the formation of an exfoliated structure upon 
incorporation of OM. ATR-FTIR studies indicated strong molecular interaction among the three 
different components of the composite. The CS-OM-HA composites exhibited a reduction in 
swelling, degradation and protein adsorption; whereas an enhancement in bioactivity was 
witnessed as evidenced by SEM analysis. Furthermore, the CS-OM-HA composites showed a 
significant enhancement in mechanical (tensile) property in comparison with pure chitosan (CS) 
and CS-OM composites. An in vitro cytotoxic assay was also performed to determine the 
biocompatibility of the prepared CS based composites. The results showed that the prepared CS 
based composites were non-toxic. From the study, it can be concluded that the novel CS-OM-HA 
composite with improved in vitro biological and mechanical properties has wide potential in non-
load bearing orthopedic applications. 
 
Keywords: Chitosan, hydroxyapatite, organically modified montmorillonite, bioactivity, 
biocompatibility 
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1. INTRODUCTION 
The use of porous polymer/bioceramic composites to repair and replace injured bone 
tissue has been a well-established area of interest. The fabrication of materials that can match 
both mechanical and biological properties of human bone tissue matrix is a critical concern in 
orthopedic treatment. Keeping this aforementioned fact in mind, attempts have been made to 
recreate nanoscale topographical cues from the extracellular environment with improved 
levels of biofunctionality [1].  
Chitosan (CS) consists of D-glucosamine and N-acetyl glucosamine units linked by β 
(1-4)-glycosidic bonds, deacetylated form of the natural polymer chitin. Chitosan is widely 
used in making bone grafts because of its structural similarity to the various 
glycosaminoglycans (GAGs) found in the extracellular matrix (ECM) of bone, 
osteoconductivity to enhance bone formation both in vitro and in vivo, biocompatibility, non- 
toxic degradation products etc. [2]. Chitosan forms polyelectrolyte complexes (PECs) due to 
its polycationic nature [3]. Unlike chitosan’s biocompatibility, its thermal stability, hardness 
and bioactivity need to be improved by incorporation of biologically active molecules like 
hydroxyapatite [4]. Glutaraldehyde (GA) (CH2(CH2CHO)2), is used as a cross-linking agent 
in the preparation of chitosan based bone grafts ,despite of its cytotoxicity [5].   
Hydroxyapatite (HA) [Ca10(PO4)6(OH)2], owing to its excellent bioactivity, 
osteoconductivity, and  chemical and physical resemblance to the mineral constituents of 
human bone, has been a preferred bioceramic in the fabrication of composite for orthopedic 
applications. Hydroxyapatite promotes the interaction between host bone and grafted material 
by binding to the natural bone through biochemical bonding [6]. However, HA based 
scaffolds are extremely brittle. They do not have enough mechanical integrity to be used as  
hard-tissue implants. In order to improve mechanical properties of hydroxyapatite scaffold, 
most often chitosan is incorporated in hydroxyapatite while preparing composites. The 
formation of coordination bonds between the amine groups of chitosan and calcium ions of 
HA leads to the enhancement of mechanical properties [7]. Kong et al. have synthesized 
porous chitosan/HA composite scaffolds using the lyophilisation method with improved 
biocompatibility and bioactivity as compared to pure chitosan scaffolds.  Addition of HA 
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resulted in more apatite formation on the composite scaffolds than that on the pure chitosan 
scaffolds. Incorporation of HA also increased the mechanical property composite scaffolds [8-
10]. The results of other studies have shown that chitosan/HA composite scaffolds were found 
to be osteoconductive in nature [11]. 
Montmorillonite (MMT) is basically nanoclay that acts as a filler material due to its 
high surface area to volume ratio [12]. Studies have reported that incorporation of MMT even 
in lower concentration can greatly enhance the mechanical properties of the composites [13]. 
MMT clay can be modified organically by exchanging the cations present in the interlayer 
with cationic surfactants such as alkylammonium salts to increase its interlayer d-spacing so 
as to facilitate the exfoliation of the silicate layers within the polymer matrix. In this work, 
montmorillonite has been modified organically with alkylammonium salts in order to improve 
its miscibility with the polymer matrix [15]. 
Microwave chemistry has been receiving remarkable attention, owing to its powerful 
thermal effect that helps in completion of the reactions in the shortest possible time by means 
of rapid and uniform heating [16]. Beşkardeş et al. have reported synthesis of chitosan–
hydroxyapatite superporous hydrogel composites using a combination of microwave 
irradiation and gas foaming with improved porosity and osteocompatibility [17]. 
There have been a few studies focused on the use of MMT clay and MMT-HA along 
with CS for preparing nanocomposite for orthopedic applications [12-15, 18-21]. Ambre et al. 
developed a novel nanocomposite containing chitosan/polygalacturonic acid-hydroxyapatite-
5-aminovaleric acid modified montmorillonite (MMT) clay using freeze drying technique, 
with improved mechanical, osteoconductivity for bone tissue engineering [14]. But the use of 
MMT clays modified with alkylammonium salts in the preparation of polymer composites for 
non-load bearing for orthopedic applications is not reported in literature. This work aims at 
developing a novel chitosan (CS)-organically modified montmorillonite (OM)-hydroxyapatite 
(HA) porous composites with improved physicochemical, in vitro biological and mechanical 
properties for non-load bearing orthopedic applications by combining microwave irradiation 
and gas foaming method. Sodium carbonate was used as gas blower in the experiment that 
resulted in release of CO2 and a porous composite was formed. Synthesized composites were 
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carefully studied using X-ray diffraction (XRD), attenuated total reflectance-fourier transform 
infrared spectroscopy (ATR-FTIR), and scanning electron microscopy (SEM). Furthermore, 
mechanical properties and in vitro biological studies such as, swelling, degradation, 
bioactivity, protein adsorption and cytotoxicity were carried out to establish its relevance as a 
biomaterial for non-load bearing orthopedic applications. 
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2. LITERATURE REVIEW 
In recent years, there has been a significant progress in the fields of organ 
transplantation and surgical reconstruction to treat the loss of organs or bone tissue.  However, 
the shortcomings associated with autografting and allografting transplantation, such as 
inherent donor site limitations, tissue rejection and disease transfer respectively, have paved 
the way of the development of making novel bone grafts. The composites made up of ceramic 
and polymeric materials ought to exhibit excellent degradation, biocompatibility and 
mechanical strength [22]. 
2.1 Biodegradability 
Biodegradable polymers are supposed to decompose in a living body without leaving 
any of its degradation products in tissues. These polymers and their degradation products are 
not supposed to elicit any immunogenic reaction or any toxicity and their degradation rate 
should match with the curing rate of tissues. The polymers should have enough mechanical 
integrity to withstand the stress incurred on bone tissue during cycling loading and unloading 
[23]. 
2.2 Biocompatibility 
Biocompatibility refers to the compatibility of a material with the host tissue that 
includes physical, chemical, biological and structural suitability of the material to the host 
tissue [24]. The tensile strength and toughness of bone are assigned the flexible collagen 
reinforced with HA [25]. 
2.3 Mechanical Strength 
The mechanical strength of composites is of particular importance while making bone 
grafts, since they are closely linked to the structural stability and durability in practical 
applications. The composites ought to have enough mechanical strength to function properly 
form the time of implantation to the completion of tissue remodeling process. A reduction in 
composite porosity greatly enhances the mechanical properties. Studies have reported that 
increasing porosity have resulted in decrease of mechanical strength [20]. 
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2.4 Polymer-Bioceramic composites 
Chitosan has been choice of biopolymer candidates in making bone grafts because of 
non-toxic degradation products. Tang et al. fabricated chitosan/hydroxyapatite with excellent 
hard tissue biocompatibility and osteoconductivity [26]. Jayabalan et al. have reported a 
biocompatible and osteocompatible nanocomposite containing calcined HA nanoparticles 
[27]. The electrospun nanofibers of HA/chitosan with compositional and structural features 
close to the natural mineralized nanofibril counterparts were prepared by Zhang et al. for bone 
tissue engineering applications [28]. Kashiwazaki et al. investigated the biocompatibility and 
biodegradation of an innovative porous chitosan/hydroxyapatite nanocomposite synthesized 
using co-precipitation and porogen leaching [29]. Chitosan/poly vinyl alcohol electrospun 
nanofibers were prepared with an average diameter from 100 to 50 nm [30]. A macroporous 
bioactive chitosan/hydroxyapatite scaffold was synthesized through phase separation [31]. 
Zhao et al. fabricated a biodegradable 3D hydroxyapatite/chitosan–gelatin composite scaffold 
for bone tissue engineering applications [32]. In a similar study, Zhao et al. reported two types 
of composite scaffolds, chitosan–gelatin and hydroxyapatite/chitosan–gelatin. 
Hydroxyapatite/chitosan–gelatin composite scaffolds have shown better osteoinductivity [33]. 
Liuyun et al. prepared nanohydroxyapatite/chitosan/carboxymethyl cellulose biocompatible 
composite scaffolds by freeze-drying method. The results of in vivo showed that the scaffold 
has a good biocompatibility and can be used for bone tissue engineering [34]. 
2.5 Polymer-clay nanocomposites 
The challenge of developing composites with adequate mechanical properties presents 
a unique problem in the field of tissue engineering. Polymer-clay nanocomposites (PCNs) 
seem to possess tremendous potential with regard to the aspect of achieving adequate 
mechanical properties. The use of MMT clay for the preparation of PCNs was pioneered by 
the Toyota research group in 1990 when they reported significant improvement in mechanical 
properties of the PCNs composed of low MMT clay loadings [35]. Recent studies have 
reported usage of modifiers to increase the miscibility of clay in the polymer. The backbone 
chain length and the functional groups present in the modifier affect the d-spacing of the clay. 
Also, it was found in this study that the backbone chain length of the modifier has similar 
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magnitude of influence on the d-spacing of the clay as that of the functional groups present in 
the modifier [36]. Montmorillonite’s ability to absorb various toxins and cross the 
gastrointestinal barrier to facilitate drug delivery, encourage its use for tissue engineering 
applications [14]. Wang et al. developed a biopolymer chitosan/montmorillonite 
nanocomposite with improved thermal stability and mechanical properties [18]. Zhuang et al. 
prepared an intercalated gelatin/montmorillonite–chitosan nanocomposite with controlled in 
vitro degradation and excellent biocompatibility [19]. Zheng et al. synthesized a 
nanocomposite scaffold containing gelatin, montmorillonite and chitosan with improved 
mechanical properties and tailored degradation rate [13]. Katti et al. reported a novel 
chitosan/montmorillonite/hydroxyapatite nanocomposite with improved mechanical property 
and good biocompatibility for biomedical applications [21]. Ambre et al. fabricated a novel 
nanocomposite containing chitosan/polygalacturonic acid-hydroxyapatite-5-aminovaleric acid 
modified montmorillonite (MMT) clay using freeze drying technique, with improved 
mechanical, osteoconductivity for bone tissue engineering [14]. Olad et al. prepared a novel 
chitosan–gelatin/nanohydroxyapatite–montmorillonite composite scaffold using freeze 
drying, with improved physicochemical, in vitro biological and mechanical properties for 
tissue engineering applications [20]. 
2.6 Microwave irradiation and its incorporation in composite synthesis 
Microwave has received an unprecedented attention owing to its powerful thermal 
effect that helps in completion of the reactions in the shortest possible time by means of rapid 
and uniform heating [16]. Ge et al. used microwave irradiation to synthesize and characterize 
a novel adsorbent containing chitosan cross-linked with both epichlorohydrin and EDTA 
dianhydride [37]. Lee et al. made the use of microwave heating to promote thermal 
crosslinking of polyethylene glycol containing microstructures. [38]. Shi et al. prepared a 
cross-linked poly (N-isopropyl-acryl amide) hydrogels in a microwave oven with porous 
morphology and equilibrium swelling ratios [39]. Beşkardeş et al. used combination of 
microwave irradiation and gas foaming to synthesize chitosan–hydroxyapatite superporous 
hydrogel composites with improved porosity and osteocompatibility [17].  
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2.7 Objective of the work 
The objective of this work was to develop porous chitosan (CS)-organically modified 
montmorillonite (OM)-hydroxyapatite (HA) composites by combining microwave irradiation 
and gas foaming and to characterize it for mechanical, physiochemical, and in vitro biological 
properties.  
 
 
 
 
 
 
 
 
 
 
 
 10  
 
 
CHAPTER 3 
 
MATERIALS AND METHODS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 11  
 
3. MATERIALS AND METHODS 
3.1 Materials 
Chitosan (CS) (medium molecular weight, degree of deacetylation 75%), 
montmorillonite (MMT), diammonium phosphate ((NH4)2HPO4), calcium nitrate tetrahydrate 
(Ca (NO3)2.4H2O), cetyl trimethyl ammonium bromide (CTAB), bovine serum albumin 
(BSA), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), penicillin-
streptomycin solution obtained from Himedia, India were used in this study. Dulbecco 
modified eagle’s medium (DMEM) was purchased from Gibco, India. Fetal Bovine Serum 
(FBS) was procured from Sigma Aldrich, India and dimethyl sulphoxide (DMSO) was 
supplied by SRL, India. All the chemical reagents were analytical grade and were used 
without further purification. Distilled water was used throughout the experiment. 
3.2 Methods 
3.2.1 Solid state synthesis of hydroxyapatite (HA) (Ca10 (PO4)6(OH)2) 
To prepare HA via solid state route, diammonium Phosphate ((NH4)2HPO4) and 
calcium nitrate tetrahydrate (Ca (NO3)2.4H2O) were used as precursors of phosphate and 
calcium, respectively. Sodium bicarbonate (NaHCO3) was used as a gas foaming agent. HA 
was prepared using the solid-state reaction at room temperature according to the following 
chemical equation [40]: 
 6((NH4)2HPO4 + 10 Ca (NO3)2.4H2O + 8 NaHCO3             Ca10 (PO4)6 (OH)2   + 12 NH4NO3 + 8 
NaNO3 + 8 CO2    + 10 H2O                                                                                     (1)                                                                                     
The desired Ca/P ratio of 1.67 of HA was kept constant. The reactants were blended 
and grounded using mortar and pestle. After aging 24 h, the sample was washed several times 
with ethanol and de-ionized water to ensure complete removal of the by-product, followed by 
drying at 80ºC in an oven for 6 h.  The dried sample was calcined at 650 0C for 1 h to obtain 
HA (Fig. 1). 
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Fig. 1 Flow chart of solid state synthesis of hydroxyapatite. 
3.2.2 Organic modification of montmorillonite (MMT) 
Initially, 10 g of MMT was added to a 1000 ml of distilled water and stirred it at 80 0C 
for 24 h. Another solution containing Cetyl trimethyl ammonium bromide (CTAB) was 
prepared by adding 5 g of CTAB to 100 ml of distilled water. Freshly prepared CTAB solution 
was added to the MMT solution and stirred it for another 10 h to accomplish the cationic-
exchange reaction. The final sample was filtered and dried to obtain organically modified 
montmorillonite (OM). 
3.2.3 Preparation of porous chitosan-organically modified montmorillonite-
hydroxyapatite (CS-OM-HA) composite  
Chitosan solution was prepared by dissolving 2 % (w/v) chitosan in 2 % (v/v) acetic 
acid solution with stirring at room temperature to get a perfectly transparent solution. Then 
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OM (10 wt%, respect to chitosan amount) was dispersed in the CS solution for 24 h by 
continuous stirring on a magnetic stirrer at 500 rpm and this suspension was further 
ultrasonicated for 5 min to get a homogeneous solution.  
 
Fig. 2  Schematic representation for the preparation of porous CS-OM-HA composite. 
In the second step, HA (10 wt%, respect to chitosan amount) was disseminated in the 
CS-OM solution for 24h by continuous stirring on a magnetic stirrer at 500 rpm. In order to 
get a perfect dispersion, solution was further ultrasonicated for 5 min and then glutaraldehyde 
solution (1%) was added drop wise and stirred for another 20 min at room temperature. Prior 
to pouring the cross-linked product into a 12-well polystyrene tissue culture plate, 0.9% (w/w) 
sodium bicarbonate was added to it. Finally, gas foaming took place in a kitchen microwave 
oven with 300W for 20s. The synthesized samples were then kept for freezing in refrigerator 
at -20ºC for 22 h and exposed at 37ºC for 2 h for thawing to complete one freeze thawing 
cycle. This cycle was repeated twice to obtain CS–OM–HA composites and then composites 
were subjected to freeze drying for 48 h in order to remove water content. Same procedure 
was used to synthesize pure CS and CS–OM composites to compare with CS–OM–HA 
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composite as schematically represented in Fig. 2. 
3.3   Physicochemical Characterization 
3.3.1 Scanning electron microscopy  
The surface morphology and pore size of the prepared composites (CS, CS-OM and 
CS-OM-HA) were examined under the scanning electron microscope (SEM) (JEOL JSM 
6480LV, USA). Prior to analysis, the samples were cut into thin slices and coated with gold 
using a sputter coater. 
3.3.2 X-ray diffraction analysis 
The XRD patterns of MMT, OM were obtained in the scan range of 2θ=3-40º whereas, 
the XRD patterns of HA was obtained at 2θ=20º-60º, respectively. The X-ray diffraction 
(XRD) patterns of composites (CS, CS-OM and CS-OM-HA) were obtained for a scan range 
of 2θ=3-60º to investigate the phase content of the composites. All the experiments were done 
at a scan rate of 5º/min with a step size of 0.05º, using Rigaku Ultima IV diffractometer 
(Japan) using CuKα radiation (λ=1.5418 Å). 
3.3.3 Attenuated total reflectance-fourier transform infrared (ATR-FTIR) 
spectroscopy 
Attenuated total reflectance-fourier transform infrared (ATR-FTIR) spectra of 
individual components ( MMT, OM, HA) as well as the composite  (CS, CS-OM, and CS-
OM-HA) were obtained using Bruker, Alpha E spectrophotometer (Germany) in the range of 
4000-520 cm-1 at a spectral resolution of 4 cm-1. 
3.4 Mechanical (tensile) properties 
The tensile properties of the composites were evaluated using a universal testing 
machine (UTM) (ElectroPuls E1000, Instron, UK). Tensile test was carried out at according to 
ASTM D3039 standard [42].  The testing was done at room temperature with a crosshead 
speed of 2 mm/min.  A load cell of 250 N was used. 
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3.5 In vitro biological evaluation 
3.5.1 Water absorption study (swelling test) 
The water absorption content of samples were determined by immersing the samples 
(with size of size 1cm x 1cm) in phosphate-buffered saline (PBS, pH=7.4) at room 
temperature for 24 h. The dry weights of the composites were calculated prior to immersion 
(Wd). Composites were immersed in PBS and their wet weights were recorded (Ww) after a 
predetermined time (24 h).The swelling percentage Sw (%) was determined using the 
following equation [20]:  
        𝑺𝒘(%) = 
𝑾𝒘−𝑾𝒅
𝑾𝒘
𝑿𝟏𝟎𝟎%                     (2) 
where Ww and Wd represented the wet and dry weights of the composites, respectively. Three 
samples were tested for each system and the average values were taken. 
3.5.2 In vitro degradation 
The in vitro degradation of the composites (of size 1 cm x 1 cm) was carried out by incubating 
the samples in PBS at 37°C. The initial weights of the composites were determined before 
immersing (W0) into PBS. At regular intervals, the samples were taken out from the PBS, 
rinsed with distilled water and dried in hot air oven for 4 days prior to recording the weight 
(Wt). The degradation percentage D (%) was determined by the following equation [13]: 
                                  
     D (%) = 
𝑾𝟎−𝑾𝒕
𝑾𝟎
 𝑿 𝟏𝟎𝟎%                                  (3) 
where W0  and Wt represented the initial and weights at time t (after 4 days), respectively. 
Three samples were tested for each system and the average values were taken. 
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3.5.3 In vitro bioactivity study 
The in vitro bioactivity of the composite was evaluated by examining the apatite 
formation on the samples after immersing in simulated body fluid (SBF). The SBF solution 
was prepared as per the protocol suggested by Kokubo et al. [41]. The samples were (of size 
1x1 cm
2
) incubated in simulated body fluid (SBF) at 37°C in a constant temperature water 
bath for 21 days. The samples were removed, rinsed with distilled water and dried at 37°C for 
12 h. The samples were observed under scanning electron microscopy (SEM) to study the 
morphology of the apatite formed. 
3.5.4 Protein adsorption study 
Composites (of size 1 cm x 1cm) were treated with PBS for 2 h prior to incubating in 
1 ml of bovine serum albumin (BSA) solution (1 mg/ml BSA in PBS) at 37 °C for 24 h.  After 
24 h the samples were removed and centrifuged at 4000 rpm for 10 min. The amount of 
adsorbed protein was quantified using Bradford assay. Initially, 100 μl aliquot of the non-
adsorbed protein solution was mixed with 1 ml of Bradford reagent and 2 ml of distilled 
water. The protein concentration was determined by UV spectrophotometer (double beam 
spectrometer 2203, SYSTRONICS, India) measurement at 595 nm. Measurements were 
performed in triplicates for each time. 
3.4.5 Cell viability assay 
Cell culture studies were conducted using MG 63 cell line from NCCS, Pune, India. 
Dulbecco’s modified eagle’s media (DMEM) supplemented with 10% FBS and penicillin-
streptomycin was used to culture osteoblast cells. Prior to cell seeding, the composites were 
placed in a 24-well culture plates and incubated with culture medium for 3 h at 37ºC in a 
humidified incubator with 5% CO2. Then cells were seeded drop wise on the composites 
(1x104 cells/100 µl of medium/composite) after removing culture medium from the 
composite. Subsequently, the cell seeded composites were kept at 37ºC in a humidified 
incubator with 5% CO2 for 48 h in order to allow the cells to attach to the composites. The cell 
viability on the composite constructs was measured using 3-(4, 5-dimethylthiazol-2-yl)-2, 5-
diphenyltetrazolium bromide (MTT) assay. The samples were washed twice with PBS and 
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incubated with fresh culture medium containing 20 µl MTT solution (5 mg/ ml) at 37ºC for 4 
h in a humidified incubator of 5% CO2. The MTT solution was removed and 1 ml of dimethyl 
sulphoxide (DMSO) was added into each well in order to dissolve the formazan crystals. The 
absorbance of this solution was quantified by UV spectrophotometer (double beam 
spectrometer 2203, SYSTRONICS, India) at 570 nm. Experiments were performed in 
triplicates. 
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4. RESULTS AND DISCUSSION 
4.1 Scanning electron microscopy  
The composites with an adequate pore size and pore size distribution for ingrowths of 
cells and diffusion of nutrients should be used in orthopedic engineering. SEM micrographs 
of CS based composites are shown in Fig. 3. All the composites were appeared to be porous 
and have pore size above 100 µm. 
 
 Fig. 3 SEM micrographs of (a) CS, (b) CS-OM, and (c) CS-OM-HA composites. 
It is quite evident from the microstructures that the inclusion of OM and HA had 
reduced the pore sizes of composites (CS-OM, CS-OM-HA) as compared to pure CS. SEM 
micrographs also revealed the uniform distribution of both HA and OM particles in the 
chitosan matrix as there were no evidence of agglomeration. The carboxyl (-COOH) and 
amine (-NH2) groups of chitosan may have interacted with Ca
+2 and PO4
-3 groups of HA, 
respectively. The hydrophilicity and polycationic nature of chitosan facilitate the dispersion of 
silicate layers in the polymer matrix. These interactions may have played a pivotal role in the 
uniform distribution of both HA and OM. Yang et al. have reported that the pore size of 
scaffolds should be in the range of 65–300 µm for osteoblast proliferation and growth [43]. 
The pore size of the composites obtained from this study is within the reported range thus 
favoring the cell growth and proliferation of osteocytes. 
4.2 X-ray diffraction analysis 
The XRD patterns were obtained to check the presence of impurities and structural 
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phases in the composites.  The XRD patterns of the individual components (MMT, OM, HA) 
as well as the chitosan (CS) composites are shown in the Fig.4. The XRD patterns of pristine 
MMT correspond to JCPDS no. 13-0259 (Fig. 4 a). The peak position for pristine MMT is 
found at 2θ=6.9º but surface modification by surfactant CTAB has resulted into a peak shift in 
XRD pattern of OM (2θ=4.7º). The decrease in 2θ relates to increase in interlayer d-spacing 
of OM due to organic modification [15]. The XRD patterns of the HA synthesized through 
solid state route corresponds to JCPDS no. 72-1243, confirming formation of HA phase (Fig. 
4(b)).Strongest diffraction peaks of HA were found at 2θ values of 25.9º (002), 31.7º (211), 
32.1º (112) and 32.9º (300). The crystallite size of the synthesized powders was calculated 
using Scherrer’s formula and was found to be 65 nm. The fraction of crystalline phase (Xc) in 
HA powder has been calculated by the following equation [44]: 
                                            Xc =1- 
𝑽𝟏𝟏𝟐/𝟑𝟎𝟎
𝑰𝟑𝟎𝟎
                                                         (4) 
Where, I300 is the intensity of the (300) diffraction peak and V112/300 the intensity of the hollow 
between (112) and (300) diffraction peaks. The estimated crystallinity degree of HA was 
found to be about 38%. 
Pendekal et al. have reported that chitosan powder has two characteristics peaks 
(2θ=20.02º, 10.53º) [45]. In Fig 4 b pure CS showed a broad amorphous peak at 2θ=22.8º 
which was found to be slightly shifted from the standard diffraction peak at 2θ=20.02º. This 
may be due to the interaction between acetic acid and chitosan that hinders the formation of 
inter-and intramolecular hydrogen bonds in CS, leading to a less packed conformation [20]. 
The characteristics peak of OM at 2θ=4.7º was not observed in the XRD patterns of CS-OM 
and CS-OM-HA composite scaffolds, confirming the formation of an exfoliated structure 
[45]. The XRD pattern of CS-OM-HA composite showed the diffraction peaks at 26º and 
31.7º, indicating presence of HA in the composite. Furthermore, the peaks at 22.8º and 26.5º 
in both CS-OM and CS-OM-HA composite scaffolds were attributed to the presence of CS 
and OM, respectively. 
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Fig. 4 XRD patterns of (a) MMT and OM, (b) hydroxyapatite and (c) CS based 
composites. 
From the results, it can be concluded that presence of PO4
-3 groups on the surface of 
the HA and enhanced miscibility of OM resulted into a simultaneous interaction of OM and 
HA with the ammonium (NH3
+) ions of chitosan [20]. 
4.3 Attenuated total reflectance-fourier transform infrared (ATR-FTIR) 
spectroscopy 
Attenuated total reflectance-fourier transform infrared spectroscopy (ATR-FTIR) 
provides specific information about chemical bonding and molecular structures. The ATR-
FTIR spectra of the individual components (HA, OM and MMT) as well as of the CS 
composites (CS, CS–OM, and CS–OM-HA) are shown in Fig. 5. Band assignments for 
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individual components (MMT, OM and HA) as well as for the CS based composites (CS, CS–
OM, and CS–OM-HA) are given in Tables I and II, respectively. 
 
Fig. 5 ATR-FTIR spectra of (a) HA, MMT and OM, (b) CS based composites. 
In the ATR-FTIR spectrum of MMT, the bands at 527 and 1031 cm-1 were assigned to 
Si–O–Al deformation and Si–O stretching, respectively. The low intense band corresponding 
to OH bending of H2O was observed at 1639 cm
-1. The band related to structural OH 
stretching was observed at 3624 cm-1. In case of OM, the bands related to CH2 stretching 
modes of CTAB were observed at 2853 and 2928 cm-1 along with the bands at 527 and 1031 
cm-1.  Also, the bands associated with OH- bending of water and structural OH- stretching 
were shifted to 1655 cm-1 and 3626 cm-1, respectively [46]. The ATR-FTIR spectra of HA 
showed the bands related to stretching modes of PO4
-3 were observed at 1043 and 962 cm-
1.The bands between 602–567 cm-1 were assigned to bending vibrations of phosphate groups 
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present in HA. 
The bands at 3570 and 630 cm-1 were related to the stretching and liberation modes of 
OH, respectively. Also, low intense band of adsorbed water (stretching) was present at 1642 
cm-1 [40]. 
Table I Band assignments for individual components 
 
Band Assignment Wavenumber 
MMT 
(cm-1) 
OM 
 
      HA 
Structural OH- stretching  
Stretching of OH-  
Asymmetric  C-H stretching  from CTAB 
Symmetric  C-H stretching of CTAB 
OH deformation of H2O  
Stretching from adsorbed water 
Asymmetric stretching of phosphate 
Si-O stretching from clay 
Symmetric stretching of phosphate 
Structural OH- 
Bending vibrations of phosphate 
Si–O–Al vibration from clay 
 3624 
    - 
    - 
    - 
 1639 
    - 
    - 
 1031 
    - 
    - 
    - 
  527 
 3626 
    - 
 2928 
 2853 
 1655 
     - 
     - 
 1031 
     - 
     - 
     - 
  527 
          - 
        3570 
          - 
          - 
          - 
        1642 
        1043 
           - 
         962 
         630 
     602-567 
           - 
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Table II Band assignments for CS based composites 
Band Assignment Wavenumber 
CS 
 (cm-1) 
  CS-OM 
      
     CS-OM-HA 
Structural OH- stretching from clay 
Stretching of OH- from hydroxyapatite   
N-H stretching of chitosan 
C-H asymmetric stretching of chitosan 
C-H symmetric stretching of chitosan 
Amide I bands from acetamide group of chitosan 
Amide II bands from acetamide group of chitosan 
Symmetric stretching of carbonyl from COO− group 
C-H bending in amide group 
CH bending vibrations of the ring 
C–O–C in glycosidic linkage 
Si-O stretching from clay 
Skeletal vibrations involving C–O stretching 
Skeletal vibrations involving C–O stretching 
CH deformation vibration of β-pyranose 
O–P–O bending from hydroxyapatite 
Si–O–Al vibration from clay 
- 
 -                                 
3400     
2920 
2851 
1643 
1546 
1404 
1375 
1324 
1153 
   - 
1067 
1021 
 897 
   - 
   - 
      3626 
 - 
      3400  
      2915 
      2845 
      1640 
      1544 
      1403 
      1376 
      1322 
      1153 
      1031 
      1069 
      1020 
       897 
         - 
       527 
           3626 
           3570  
           3400  
           2922   
           2849  
           1633  
           1538 
           1403 
           1374  
           1321 
           1153 
           1031 
           1060 
           1014 
            898 
         602-567 
            527 
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In the pure chitosan (CS) spectrum, band corresponding to N–H stretching was 
observed at 3400 cm−1 [26]. The bands at 2920 and 2845 cm-1 correspond to the CH 
stretching. The broad bands at 1643 and 1546 cm-1 were attributed the presence of amide I 
and amide II groups. The sharp band at 1404 cm-1 was assigned to stretching of carbonyl from 
COO− group.  The low intense bands at 1375 and 1321 cm-1 were corresponded to CH 
bending vibrations of the ring. The characteristics peaks of C-O-C glycosidic linkage were 
observed in the region of 1153-1021 cm-1. The absorption band corresponding to the CH 
deformation vibration of β-pyranose was observed at 897 cm-1 [20,21]. The N-H bending 
region of chitosan was shifted to 1544 cm-1 and 1538 cm-1 in from 1546 cm-1 in CS–OM and 
CS-OM-HA composites, respectively. It was also observed that the band corresponding to OH 
bending of H2O in OM got shifted from 1655 cm
−1 to 1659 cm−1 and 1665 cm−1 in CS-OM 
and CS-OM-HA composites, respectively. This confirms the occurrence of different 
interactions like hydrogen bonding and electrostatic interactions, of the chitosan with the OM 
and HA. However, both CS-OM and CS-OM-HA composite have shown the characteristics 
peaks of C-O-C glycosidic linkage and the absorption band corresponding to the CH 
deformation vibration of β-pyranose at 1153-1021 cm-1 and 897 cm-1, respectively. The bands 
seen near 602-567 and 3570 cm−1 in case of CS-OM-HA composite  were attributed to the O–
P–O bending of phosphate group and stretching mode of OH water present in HA [20,21]. 
Also, the bands seen around 527, 1031, and 2928, 2853 cm−1 in case of CS-OM and CS-OM-
HA composite, correspond to the Si–O–Al deformation, Si–O stretching and CH stretching 
modes of OM clay, respectively. Furthermore, the structural OH- stretching of OM appeared 
in CS-OM and CS-OM-HA composites at 3626 cm−1 which confirms the presence of OM in 
both the composites. From the ATR-FTIR spectra of the composites, it can be concluded that 
both OM clay and HA are successfully incorporated in the CS based composites. 
4.4 Mechanical (tensile) properties 
The composite must possess enough mechanical strength to withstand stress incurred 
by newly formed tissue in vitro till its implantation in vivo. The average values of the Young’s 
modulus, tensile strength, and elongation at break of the pure CS, CS–OM and CS–OM-HA 
composites are reported in Table III. It was observed that there was a significant increase in 
tensile strength of composites over the polymer. CS-OM and CS-OM-HA composites 
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exhibited tensile strengths of 0.38 and 0.56 MPa, respectively. The tensile strengths have 
increased up to 5.5% and 55% in CS-OM and CS-OM-HA composites, respectively. Further, 
addition of OM and HA increased the modulus to a value of 5.02 MPa and 24.9 MPa, in CS-
OM and in CS-OM-HA composites, respectively. This drastic increase in elastic modulus can 
attributed to the strong interfacial interactions among chitosan, OM and HA, influencing the 
overall mechanical properties of the CS based composites. It is well known that the interface 
between filler particle and polymer matrix has a significant effect on the tensile properties of 
the composites.   
Table III Tensile properties of CS based composites 
 
 
 
 
 
 
The elongation of the CS-OM composites have increased as compared to pure CS 
composite, confirming the increase in plasticity of the sample due to incorporation of OM. 
However, inclusion of HA induces brittleness in the CS-OM-HA composites, resulting into a 
reduction in elongation in CS-OM-HA as compared to pure CS.  From the results, it is evident 
that the overall tensile property achieved in CS-OM-HA composite was the best amongst CS 
and CS-OM composites. 
4.5 Water absorption study (swelling test) 
The swelling of composites facilitates the infiltration of cells into the composites in a 
three dimensional fashion. The swelling profile of pure chitosan (CS) and its composites is 
shown in Fig. 6. The results have shown that incorporation of HA and OM  in the polymer 
 
Samples 
Tensile strength 
(MPa) 
Elastic modulus 
 (MPa) 
Extension  
at   break 
   (mm) 
CS 
CS-OM 
CS-OM-HA 
0.36 ± 0.057 
0.38 ± 0.042 
0.56 ± 0.270 
4.62 ± 0.78 
5.02 ± 1.85 
24.9 ± 3.24 
4.59 ± 0.2 
5.36 ± 2.05 
2.56 ± 1.6 
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matrix brought in the swelling behavior of the CS based composites. HA forms a temporary 
barrier preventing water permeating into the composite. HA decreases the hydrophilicity of 
the chitosan by binding to the hydrophilic –COOH and –NH2 as well. Incorporation of OM 
also played a role in reduction of swelling. The sheets of OM too have formed a barrier that 
inhibits the interaction between polymer macromolecules and water molecules, leading into 
lowering of water content in both CS-OM and CS-OM-HA composites. Hence, the swelling 
properties of CS based composites can be tailored by using appropriate amount of inorganic 
phase. 
 
 Fig. 6 Swelling behavior of CS based composite. 
4.6 In vitro degradation 
Implant materials are supposed to be degradable and the rate of degradation should 
match with rate of new tissue formation. The degradation profile of pure chitosan (CS), CS-
OM, and CS-OM-HA composites after 28 days immersion in PBS is presented in Fig. 7. The 
degradation rate of pure chitosan (CS) composite was greater as compared to CS-OM, and 
CS-OM-HA composites and found to be decreased with the addition of OM and HA in the 
chitosan matrix. After 28 days of in vitro biodegradation, the mass of pure CS, CS-OM, and 
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CS-OM-HA composites were degraded by 32%, 23.8%, and 15.3%, respectively. 
Furthermore, HA dissolves slowly in vitro and the strong interaction between polymer 
macromolecule and OM clay reduce the number of hydrophilic groups in the composites. It 
depresses the solvent uptake thereby protects the polymer from degradation in PBS. 
Therefore, it can be concluded that the degradation rate can be controlled by adjusting the OM 
and HA contents in the polymer matrix. 
 
Fig. 7 In vitro degradation profile of CS based composites.  
4.7 In vitro bioactivity 
The CS based composites were analysed for their in vitro bioactivity by immersing 
them in SBF solution for 21 days. After 21 days, apatite formation on the surface of the 
composite pores was observed using scanning electron microscopy (JEOL JSM 6480LV, 
USA). SEM micrographs (Fig. 8) have shown apatite formation on the surface of CS based 
composites. The amount of apatite formation on the surfaces of the composites increased in 
the order of CS-OM-HA > CS-OM > CS. In this study, pure CS had no active site on its 
surface to trigger the apatite formation. In case of CS-OM, Si-OH (silanol) group, the 
chelating agents of Ca+2 and PO4
-3 ions present in SBF (from clay) was present on its surface, 
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facilitating apatite deposition [48]. HA particles acted as nucleation sites in the CS-OM-HA 
composites. Also, OM clay with Si-OH (silanol) group on its surface has a synergetic effect 
with HA to induce the apatite formation. Consequently, apatite has formed more efficiently on 
the CS-OM and CS-OM-HA composites than on the pure CS. 
 
Fig. 8 SEM micrographs showing apatite formation on (a) CS (b) CS-OM and (c) CS-
OM-HA composites. 
4.8 Protein adsorption study 
The occurrence of functional groups such as, amine (–NH2), carboxyl (-COOH), and 
hydroxyl (-OH) on the surface of the composite greatly influences protein adsorption [49]. 
The amount of adsorbed BSA decreased in the sequence of CS > CS-OM > CS-OM-HA. The 
protein adsorption profiles of CS based composites are shown in Fig. 9. The amount of 
protein adsorbed reduced by 4.77% and 7.52% on CS-OM and CS-OM-HA composites, as 
compared to pure CS. In this study, the presence of aforementioned hydrophilic groups in 
pure CS resulted in highest protein adsorption among CS-OM and CS-OM-HA composites. 
The interaction with the hydrophilic groups (-COOH, -OH, –NH2) became more prominent in 
the presence of PBS as a solubilising medium. Montmorillonite had hydroxyl (-OH) groups 
on its surface, but CTAB modification incorporated cations in place of anionic hydroxyl (-
OH) groups [15]. Consequently, active sites (hydrogen bond forming sites) for BSA 
attachment were no longer available on the surface of organically modified montmorillonite, 
led to the formation of a complex with CS that had less affinity towards BSA. Basu et al. have 
reported that hydroxyapatite interacts electrostatically with BSA via electrostatic interaction 
between the Ca+2 cations and PO4
-3 anions of HA with the COO- anion and NH3
+ cations of 
the BSA protein, respectively [50]. 
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Fig. 9 Protein adsorption profile of CS based composite. 
However, in case of CS-OM-HA composite these active sites for BSA interaction were 
already taken up by COO- and NH3
+ of chitosan. Hence, no active site was present on the 
surface of HA to interact with BSA.  From the results, it can be concluded that the addition of 
HA and OM would suppress of non-specific protein adsorption, which could reduce the 
fibrosis tissue thickness and macrophages adhesion in vivo. 
4.9 Cell viability assay 
Osteoblast cells’ response on CS based composites was investigated by MTT assay. 
The MTT assay results demonstrated (Fig.10) a significant increase in cell viability of all 
composites as compared to previous study [21]. Katti et al. have reported 40% and 28% cell 
viability with CS-MMT and CS-HA-MMT scaffolds, respectively [21].  But incorporation of 
OM into the polymer matrix in place of MMT has induced a drastic increase of cell viability 
of CS-OM (68.5%) and CS-OM-HA (54.5%) composites, respectively. Sirousazar et al. have 
already reported cytocompatibility of OM containing PVA/clay nanocomposite hydrogels 
towards K562 (erythroleukemia) cell line [51]. From the results, it can be concluded that the 
CS based composites were non-cytotoxic to MG 63 cell line.  
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Fig. 10 Cell viability results of CS based composite. 
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5. CONCLUSION 
A novel CS-OM-HA was synthesized by combining microwave irradiation and gas 
foaming method with pores in the sizes of micro range. A reduction in pore size was observed 
in this composite as compared to pure CS and CS-OM composites. The XRD results indicated 
the formation of an exfoliated structure. ATR-FTIR study demonstrated the evidence of strong 
molecular interaction among the three different constituents of the composite, which can be 
clearly observed from the shift in the band position of chitosan in the presence of OM and 
HA. Improved mechanical property and bioactivity was observed with the incorporation of 
OM and HA. The swelling, degradation and protein adsorption of CS-OM-HA composites 
were lowered in comparison to the pure CS and CS-OM composites. Cytotoxicity studies 
showed the prepared composites were non-toxic when tested with MG 63 cell line. From the 
results, it can be concluded that the novel CS-OM-HA composites can be a potential 
biomaterial for non-load bearing orthopedic applications. 
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